Menu

艾滋病药物绥美凯国内有吗

Author: Medicalhalo
Release time: 2025-10-19 11:44:20

On January 22, 2018, Glaxo announced that its joint venture ViiV Healthcare’s single-pill compound preparation for the treatment of HIV, which is based on the new generation integrase inhibitor Tyvicat, was officially launched in mainland China. This is the first single-pill compound preparation with a complete treatment plan in the field of HIV treatment in mainland China.

After an acute overdose of dolutegravir, abacavir, or lamivudine, no specific symptoms or signs other than those listed as adverse reactions have been noted.

There is no specific treatment for Suimeike overdose. If overdose occurs, the patient should receive supportive care and appropriate monitoring if necessary. Because lamivudine is dialyzable, continuous hemodialysis may be used in the treatment of overdose, but this has not been studied. It is unknown whether abacavir is eliminated by peritoneal dialysis or hemodialysis. Dolutegravir is highly bound to plasma proteins, so it is unlikely to be significantly removed using dialysis.

Recommended dosage: Adults and adolescents (weighing at least 40kg);

For adults and adolescents, the recommended dose of Trimax is one tablet once daily.

Adults or adolescents whose body weight is less than 40 kg should not be given Trimax because Trimax is a fixed-dose tablet and the dose cannot be reduced.

Trimax is a fixed-dose tablet and should not be used in patients who require dose adjustments. If one of the active ingredients needs to be discontinued or a dose adjustment is required, separate formulations of dolutegravir, abacavir, or lamivudine may be used. In these cases, physicians should refer to the respective product information for these medicines.

We also remind everyone that HIV-infected patients, regardless of their race, should be screened for carrying the HLA-B*5701 allele before starting treatment with abacavir-containing products. If the patient is known to carry the RLA-B*5701 allele, he should not take products containing abacavir. Therefore, patients must obtain sufficient examination results before using it under the doctor's advice.

Recommended related hot articles: /newsDetail/80766.html

[ 免责声明 ]  本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。